http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9237845

Outgoing Links

Predicate Object
contentType Journal Article|Review
endingPage 440
issn 1551-7144
issueIdentifier 5
pageRange 432-440
publicationName Contemporary Clinical Trials
startingPage 432
bibliographicCitation Boudes PF. The challenges of new drugs benefits and risks analysis: lessons from the ximelagatran FDA Cardiovascular Advisory Committee. Contemp Clin Trials. 2006 Oct;27(5):432–40. doi: 10.1016/j.cct.2006.04.005. PMID: 16769255.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_72a0cecca7acc4a6037809d8b33904ad
date 200610
identifier https://doi.org/10.1016/j.cct.2006.04.005
https://pubmed.ncbi.nlm.nih.gov/16769255
isPartOf https://portal.issn.org/resource/ISSN/1551-7144
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32406
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title The challenges of new drugs benefits and risks analysis: Lessons from the ximelagatran FDA Cardiovascular Advisory Committee
discusses http://id.nlm.nih.gov/mesh/M0000620
http://id.nlm.nih.gov/mesh/M0001380
http://id.nlm.nih.gov/mesh/M0022871
http://id.nlm.nih.gov/mesh/M0388208
http://id.nlm.nih.gov/mesh/M0002072
http://id.nlm.nih.gov/mesh/M0002392
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D001596Q000009
http://id.nlm.nih.gov/mesh/D000925Q000009
http://id.nlm.nih.gov/mesh/D001384Q000009
http://id.nlm.nih.gov/mesh/D056486
http://id.nlm.nih.gov/mesh/D013923Q000517
hasSubjectTerm http://id.nlm.nih.gov/mesh/D001596Q000627
http://id.nlm.nih.gov/mesh/D026683
http://id.nlm.nih.gov/mesh/D000925Q000627
http://id.nlm.nih.gov/mesh/D001384Q000627
http://id.nlm.nih.gov/mesh/D000410Q000097
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D014486
http://id.nlm.nih.gov/mesh/D017277Q000379
http://id.nlm.nih.gov/mesh/D018570
http://id.nlm.nih.gov/mesh/D014481
http://id.nlm.nih.gov/mesh/D008099Q000187
http://id.nlm.nih.gov/mesh/D014859Q000627
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11167
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54678486
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9410
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3667f6a0c97490758d7dc9659d01ea34
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93971978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9574101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5478933
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73101855

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128926582
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245255101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129046631

Total number of triples: 56.